Relapsed or Refractory Chronic Lymphocytic Leukemia

People with relapsed or refractory chronic lymphocytic leukemia are asked to participate in a research study being conducted by Monter Cancer Center.

You may be eligible to participate in this study if you:

• Are at least ≥ 18 years of age
• Are histologically confirmed with relapsed/refractory CLL
• Have at least one bi-dimensionally measurable nodal lesion
• Have adequate renal, hepatic function
• Have Adequate BM function

You may not participate in this study if you:

• Have relapsed or progressed on BCL-2 inhibitor
• Have a history of Richter’s transformation or prolymphocytic leukemia
• Have any significant, uncontrolled concomitant disease
• Have an active or uncontrolled autoimmune cytopenias
• Have received chemotherapy or radiotherapy within 14 days
• Have a history of cancer or concurrent cancer
• Have currently active, clinically significant cardiovascular disease
• Are known to be positive for human immunodeficiency virus (HIV), hepatitis B, or C
• Are pregnant, breast feeding or planning to become pregnant

Contact Information
Dina Padula, Study Coordinator
Phone: (718) 470-4745